Multidisciplinary management of Merkel cell carcinoma | 28 min
Due to the highly aggressive nature of Merkel cell carcinoma, accurate and timely diagnosis is essential to ensure optimal management. Although our understanding of…
Neoadjuvant therapy in melanoma with Georgina Long | 45 min
In this interview from Oncology News Australia, MIA’s Prof Georgina Long AO speaks with Prof Hans Prenen on a recent publication in Nature Medicine…
Multidisciplinary management of SCC and BCC | 46 min
Squamous cell carcinoma (SCC) and basal cell carcinoma (BCC) are the most common forms of non-melanoma skin cancers. They have a wide clinical and…
Update on Merkel cell carcinoma pathology | 11 min
Merkel cell carcinoma is a rare but highly aggressive neuroendocrine tumour of the skin. Early diagnosis and timely intervention are essential for improving health…
The complexities of adjuvant therapy in melanoma | 33 min
The success of immunotherapy and targeted therapy in the treatment of advanced melanoma has led to the same therapies being used in the adjuvant…
Post-melanoma checks: Who, what and how often? | 16 min
Patients require long-term surveillance after receiving melanoma treatment. Definitive evidence-based guidelines for follow-up are lacking, but sensible guidelines based on an individual patient’s risk…
Update on melanoma staging | 18 min
Accurate staging of patients with newly diagnosed melanomas is of great importance to obtain accurate estimates of prognosis and determine the most appropriate treatment…
Systemic therapy updates in advanced melanoma | 60 min
Medical oncology has changed the way melanoma is treated and continues to evolve. In this webinar, Medical Oncologist A/Prof Matteo Carlino provides an updated…
ESMO 2020: Melanoma highlights through an Australian lens | 63 min
In this lively case-study based panel discussion, our multidisciplinary experts discuss the hot topics in melanoma from ESMO 2020 including the latest research in…